Abstract
Over the past two decades, nanotechnology emerged as an excellent alternative for overcoming the limitations and fulfilling the unaddressed issues in various fields of science and technology. Nanotechnology and nanomedicine advanced the area of biomedical research by introducing several novel platforms for disease diagnosis and therapy. This resulted in an increased demand for discovering novel methods for bulk scale preparation of nanomaterials as the conventional methods were neither economical nor eco-friendly. In this context, researchers investigated and optimized green chemistry as a promising alternative approach for producing cheap, stable, biocompatible, and bioactive nanomaterials. Several bioinspired nanomaterials were synthesized following this approach as potential theranostic candidates against many dreadful diseases including cancer. In spite of these excellent pharmacological properties of green nanomaterials, there are several challenges needed to be addressed for their successful clinical translation. The present chapter discusses the progress in synthesis methods of green nanomaterials and their theranostic applications as cancer nanomedicine along with the challenges involved in their synthesis, and biological applications. Finally, the future opportunities of the green nanoparticles as efficient cancer nanomedicine will be illustrated with concluding remarks.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
